Gilead Sciences (GILD) Net Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,568.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-2,848.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-501.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,859.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-12.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
931.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
- |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
134.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
931.00 |
| Dec 31, 2025 |
836.00 |
| Sep 30, 2025 |
2,268.00 |
| Jun 30, 2025 |
447.00 |
| Mar 31, 2025 |
8,211.00 |
| Dec 31, 2024 |
364.00 |
| Sep 30, 2024 |
-1,420.00 |
| Jun 30, 2024 |
748.00 |
| Mar 31, 2024 |
-7,788.00 |
| Dec 31, 2023 |
-220.00 |
| Sep 30, 2023 |
544.00 |
| Jun 30, 2023 |
-239.00 |
| Mar 31, 2023 |
1,531.00 |
| Dec 31, 2022 |
1,691.00 |
| Sep 30, 2022 |
-948.00 |
| Jun 30, 2022 |
-616.00 |
| Mar 31, 2022 |
-2,644.00 |
| Dec 31, 2021 |
-1,536.00 |
| Sep 30, 2021 |
2,988.00 |
| Jun 30, 2021 |
9,158.00 |
| Mar 31, 2021 |
92.00 |
| Dec 31, 2020 |
1,075.00 |
| Sep 30, 2020 |
2,817.00 |
| Jun 30, 2020 |
-9,790.00 |
| Mar 31, 2020 |
-891.00 |
| Dec 31, 2019 |
495.00 |
| Sep 30, 2019 |
-5,810.00 |
| Jun 30, 2019 |
-50.00 |
| Mar 31, 2019 |
555.00 |
| Dec 31, 2018 |
6,760.00 |
| Sep 30, 2018 |
-47.00 |
| Jun 30, 2018 |
-607.00 |
| Mar 31, 2018 |
-511.00 |
| Dec 31, 2017 |
-9,858.00 |
| Sep 30, 2017 |
-241.00 |
| Jun 30, 2017 |
-35.00 |
| Mar 31, 2017 |
-1,159.00 |
| Dec 31, 2016 |
-1,244.00 |
| Sep 30, 2016 |
-1,120.00 |
| Jun 30, 2016 |
-1,281.00 |
| Mar 31, 2016 |
-591.00 |
| Dec 31, 2015 |
631.00 |
| Sep 30, 2015 |
881.00 |
| Jun 30, 2015 |
-33.00 |
| Mar 31, 2015 |
1,350.00 |
| Dec 31, 2014 |
2,877.00 |
| Sep 30, 2014 |
2,305.00 |
| Jun 30, 2014 |
3,201.00 |
| Mar 31, 2014 |
1,931.00 |
| Dec 31, 2013 |
-683.00 |
| Sep 30, 2013 |
-450.00 |
| Jun 30, 2013 |
-732.00 |
| Mar 31, 2013 |
190.00 |
| Dec 31, 2012 |
-421.00 |
| Sep 30, 2012 |
-1,315.00 |
| Jun 30, 2012 |
-876.00 |
| Mar 31, 2012 |
-1,665.00 |
| Dec 31, 2011 |
-710.00 |
| Sep 30, 2011 |
-148.00 |
| Jun 30, 2011 |
-206.00 |
| Mar 31, 2011 |
-724.00 |
| Dec 31, 2010 |
-4,312.00 |
| Sep 30, 2010 |
-98.00 |
| Jun 30, 2010 |
224.00 |
| Mar 31, 2010 |
252.00 |
